Threonine

ret proto-oncogene ; Homo sapiens







34 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24501868 [Blood transfusions suppress erythropoiesis in anemia of prematurity]. 2013 1
2 22128160 Identification of a key motif that determines the differential surface levels of RET and TrkB tyrosine kinase receptors and controls depolarization enhanced RET surface insertion. 2012 Jan 13 2
3 16427628 A PKC-mediated backup mechanism of the MXXCW motif-linked switch for initiating tyrosine kinase activities. 2006 Feb 6 1
4 16829704 De novo multiple endocrine neoplasia type 2B with noncardiogenic pulmonary edema as the presenting symptom. 2006 Aug 1
5 17102091 Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2. 2006 Aug 1
6 17108110 Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2B. 2006 Nov 15 2
7 16254257 p-p70S6K (Thr 389) Expression in nodular sclerosing hodgkin's disease as evidence for receptor tyrosine kinase signaling. 2005 Autumn 1
8 15379552 Identification of major ERK-related phosphorylation sites in Gab1. 2004 Sep 28 1
9 15485908 Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells. 2004 Nov 1
10 15531548 Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition. 2004 Nov 1
11 12757658 [A case report and pedigree study of a single point mutation in RET proto-oncogene and type 2B multiple endocrine neoplasia]. 2003 Jan 2
12 11839664 RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes. 2002 Feb 1
13 11351254 CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome. 2001 Jun 1
14 10871866 Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice. 2000 Jun 22 3
15 9621513 Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma. 1998 1
16 9706252 [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers]. 1998 1
17 9018112 Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations. 1997 Jan 23 2
18 9075701 Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential. 1997 Apr 1
19 9393871 The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. 1997 Nov 6 3
20 9398735 A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma. 1997 Dec 1
21 8557249 Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A. 1996 Jan 1
22 8621456 The multiple endocrine neoplasia type 2B point mutation alters long-term regulation and enhances the transforming capacity of the epidermal growth factor receptor. 1996 Mar 8 3
23 8880581 Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). 1996 Sep 1
24 8884827 RET protooncogene mutational analysis in multiple endocrine neoplasia syndrome type 2B: case report and review of the literature. 1996 Sep 2
25 9074721 [Neural crest and multiple endocrinopathies]. 1996 1
26 7495285 Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. 1995 Dec 1
27 7595167 The RET proto-oncogene and cancer. 1995 Oct 1
28 7627271 Tumor-specific mutations in the tyrosine kinase domain of the RET proto-oncogene in pheochromocytomas of sporadic type. 1995 Apr 2
29 7705835 Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families. 1995 Apr 2
30 8625130 Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. 1995 Aug 1 2
31 12114809 Molecular Diagnosis of Multiple Endocrine Neoplasia (MEN) in Paraffin-Embedded Specimens. 1995 Winter 1
32 7906866 A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. 1994 Jan 27 1
33 7911697 Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. 1994 Feb 1
34 3001107 Interaction of the insulin receptor kinase with serine/threonine kinases in vitro. 1985 1